SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-020217
Filing Date
2024-01-31
Accepted
2024-01-31 07:05:56
Documents
2
Group Members
KATHERINE H. HALPERN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d629436dsc13ga.htm SC 13G/A 64500
2 EX-99.A d629436dex99a.htm EX-99.A 3230
  Complete submission text file 0001193125-24-020217.txt   69312
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 24580620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
HALPERN JOHN D (Filed by) CIK: 0001234950 (see all company filings)

Type: SC 13G/A